NextPlat (NXPL) investor relations material

Business overview and strategy

• Operates a unified platform spanning healthcare, connectivity, and global e-commerce, serving over 160 countries and 75,000+ e-commerce customers.

• Focuses on high-growth sectors: healthcare (prescription management, AI analytics) and communications & e-commerce (satellite connectivity, online brand development).

• Pursues synergistic acquisitions and leverages proprietary software to accelerate growth and expand market reach.

• Expanding healthcare services nationwide in the US, with a growing retail pharmacy footprint and 340B/long-term care contracts.

• E-commerce development targets health and wellness brands for the Chinese market, with expansion into Japan and other Asian platforms.

Financial performance and turnaround

• Achieved $54.3M in FY2025 revenue, with Q2 2026 gross margin reaching a record 40% and net loss reduced by 92%.

• Annualized cost reductions exceed $2M, including a 25%+ staff reduction, driving near-breakeven results.

• Q1 2026 revenue was $9.9M with a 35% gross margin and 9% sequential reduction in operating expenses.

• Clean balance sheet with $11.9M cash, $14.2M working capital, and no material unsecured debt as of June 2026.

• High insider ownership (46%) and low public float (~841K shares), supporting disciplined growth.

Operational highlights and recent developments

• Expanded pharmacy services to all 50 US states, with over 380,000 prescriptions filled annually.

• Launched AI-powered prescription processing and earned specialty pharmacy accreditation.

• Secured major satellite connectivity contracts, including $820K from a UK government supplier and $400K in IoT contracts.

• Expanded e-commerce into five South American countries via Mercado Libre and continued growth in Asia.

• Acquired a Pensacola-area pharmacy, adding $5.6M in profitable annual revenue.